HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haiping Zhao Selected Research

Glucose (Dextrose)

3/2024Dihydroergotamine protects against ischemic stroke by modulating microglial/macrophage polarization and inhibiting inflammation in mice.
6/2020Metabolic Syndrome and Related Factors in Chinese Children and Adolescents: Analysis from a Chinese National Study.
1/2020Silencing of microRNA-494 inhibits the neurotoxic Th1 shift via regulating HDAC2-STAT4 cascade in ischaemic stroke.
1/2020The predictive value of anthropometric indices for cardiometabolic risk factors in Chinese children and adolescents: A national multicenter school-based study.
12/2019MiR-424 prevents astrogliosis after cerebral ischemia/reperfusion in elderly mice by enhancing repressive H3K27me3 via NFIA/DNMT1 signaling.
10/2018Prevalence and risk factors of impaired fasting glucose and diabetes among Chinese children and adolescents: a national observational study.
1/2017Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization.
9/2014Effects of 2-Deoxyglucose on ischemic brain injuries in rats.
4/2014Correlation between tongue manifestations and glucose, total cholesterol, and high-density lipoprotein cholesterol in patients with acute cerebral infarction.
4/2013Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haiping Zhao Research Topics

Disease

33Ischemic Stroke
05/2024 - 06/2013
22Stroke (Strokes)
05/2024 - 07/2013
21Brain Ischemia (Cerebral Ischemia)
05/2024 - 01/2012
17Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2024 - 06/2013
16Infarction (Infarctions)
12/2022 - 01/2012
13Ischemia
05/2024 - 04/2013
10Neoplasms (Cancer)
03/2024 - 09/2011
8Inflammation (Inflammations)
03/2024 - 08/2013
8Reperfusion Injury
04/2018 - 01/2010
7Brain Injuries (Brain Injury)
03/2024 - 01/2014
6Cerebral Infarction
01/2019 - 06/2013
4Brain Edema (Cerebral Edema)
01/2022 - 01/2015
4Hypertension (High Blood Pressure)
06/2020 - 01/2015
3Neuroinflammatory Diseases
05/2024 - 01/2017
3Cerebral Hemorrhage
02/2023 - 12/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021 - 01/2021
3Edema (Dropsy)
01/2019 - 01/2012
2Hemorrhage
05/2024 - 05/2022
2Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2022
2Cicatrix (Scar)
10/2021 - 01/2021
2Dyslipidemias (Dyslipidemia)
05/2021 - 01/2020
2Breast Neoplasms (Breast Cancer)
04/2021 - 01/2020
2Moyamoya Disease (Moya-Moya Disease)
01/2021 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2015
2Hematoma
01/2019 - 12/2012
2Diabetes Mellitus
10/2018 - 09/2017
2Atherosclerosis
04/2018 - 08/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2017 - 01/2017
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2012 - 01/2010
1Pneumonia (Pneumonitis)
05/2024
1Migraine Disorders (Migraine)
03/2024
1Thrombosis (Thrombus)
12/2022
1Bone Resorption
12/2022
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2022
1Periodontitis
12/2022
1Cognitive Dysfunction
12/2022

Drug/Important Bio-Agent (IBA)

12MicroRNAs (MicroRNA)IBA
01/2023 - 06/2013
10Glucose (Dextrose)FDA LinkGeneric
03/2024 - 04/2013
9Proteins (Proteins, Gene)FDA Link
03/2023 - 01/2010
9Biomarkers (Surrogate Marker)IBA
02/2023 - 01/2017
8Neuroprotective AgentsIBA
05/2024 - 08/2015
8Long Noncoding RNAIBA
03/2024 - 01/2017
6Tissue Plasminogen Activator (Alteplase)FDA Link
03/2023 - 10/2015
6ErythropoietinFDA Link
01/2021 - 01/2014
5Oxygen (Dioxygen)IBA
03/2024 - 04/2013
5Messenger RNA (mRNA)IBA
06/2021 - 06/2013
4AntagomirsIBA
01/2023 - 08/2015
4Interleukin-10 (Interleukin 10)IBA
12/2022 - 01/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 01/2017
4Small Interfering RNA (siRNA)IBA
01/2017 - 08/2014
3InterleukinsIBA
12/2022 - 01/2021
3Therapeutic UsesIBA
12/2022 - 09/2011
3Interleukin-2 (IL2)IBA
10/2022 - 08/2020
3CytokinesIBA
05/2022 - 01/2020
3Matrix Metalloproteinases (MMPs)IBA
10/2021 - 01/2015
3LipidsIBA
05/2021 - 08/2013
3triphenyltetrazoliumIBA
01/2019 - 06/2013
3chrysophanic acidIBA
09/2018 - 09/2016
3AntioxidantsIBA
05/2016 - 08/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2016 - 08/2014
3Superoxide DismutaseIBA
10/2014 - 01/2012
2Indicators and Reagents (Reagents)IBA
08/2023 - 04/2019
2ChloridesIBA
01/2023 - 12/2016
2Interleukin-6 (Interleukin 6)IBA
12/2022 - 05/2022
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2021
2HDL CholesterolIBA
06/2020 - 04/2014
2Phosphotransferases (Kinase)IBA
01/2020 - 10/2014
2Histones (Histone)IBA
12/2019 - 05/2016
2Glial Fibrillary Acidic ProteinIBA
12/2019 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
12/2019 - 05/2016
2Circular RNAIBA
01/2019 - 01/2019
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2018 - 08/2014
2Insulin-Like Growth Factor I (IGF-1)IBA
04/2018 - 08/2013
2Malondialdehyde (Propanedial)IBA
02/2015 - 08/2014
2Protein Kinases (Protein Kinase)IBA
10/2014 - 08/2014
2SolutionsIBA
06/2013 - 01/2012
1HMGB1 Protein (HMG1)IBA
05/2024
1Small Nucleolar RNA (snoRNA)IBA
03/2024
1ImmunosorbentsIBA
03/2024
1EnzymesIBA
03/2024
1Dihydroergotamine (Agit)FDA LinkGeneric
03/2024
1Leukocyte Elastase (Neutrophil Elastase)IBA
03/2023
1Myeloblastin (Proteinase 3)IBA
03/2023
1Cathepsin GIBA
03/2023
1Serine Proteases (Serine Protease)IBA
03/2023
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
01/2023
1Ubiquitin-Conjugating EnzymesIBA
01/2023
1ArginaseIBA
12/2022
1Conditioned Culture MediaIBA
12/2022
1LipopolysaccharidesIBA
12/2022
1ThrombinFDA Link
12/2022
1ferric chlorideIBA
12/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2022

Therapy/Procedure

10Therapeutics
01/2022 - 10/2015
4Ischemic Postconditioning
01/2018 - 05/2013
2Aftercare (After-Treatment)
06/2021 - 12/2012
2Intra-Arterial Infusions
01/2016 - 03/2015
1Ligation
12/2022